PAMA: OIG Backing of CMS Heats Up Market-Based Lab Rates Controversy

PAMA Unlocks Golden Age for Innovative Diagnostics

By Chance Scott  bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…


. . . read more